[go: up one dir, main page]

AR004965A1 - Procedimiento de preparacion de derivados de fenilimidazolidina - Google Patents

Procedimiento de preparacion de derivados de fenilimidazolidina

Info

Publication number
AR004965A1
AR004965A1 ARP960105163A ARP960105163A AR004965A1 AR 004965 A1 AR004965 A1 AR 004965A1 AR P960105163 A ARP960105163 A AR P960105163A AR P960105163 A ARP960105163 A AR P960105163A AR 004965 A1 AR004965 A1 AR 004965A1
Authority
AR
Argentina
Prior art keywords
radicals
esterified
alkyl
alkenyl
aryl
Prior art date
Application number
ARP960105163A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR004965A1 publication Critical patent/AR004965A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invencion tiene por objeto un procedimiento de preparacion de derivados de fenilimidazolidina de formula (I) en la que R1 y R2 son hidrogeno, halogeno,alquilo, alquenilo, alquinilo, alquiloxi, alqueniloxi, alquiniloxi fenilo, fenoxi, nitro,trifluormetilo, arilo, ciano, amino, monoalquilamino,dialquilamino o carboxi libre esterificado, amidificado o salidificado. R3 se escoge entre el atomo de hidrogeno y los radicales, alquilo, alquenilo,alquinilo, arilo y arilalquilo, estando todosestos radicales eventualmente sustituidos con uno o varios sustituyentes escogidos entre los atomos dehalogeno, lo radicales hidroxilo, eventualmente esterificado, eterificado o protegido, alcoxi, alqueniloxi, alquiniloxi, trifluorometilo,me rcapto, ciano,arilo, ariloxi, carboxi libre esterificado, amidificado o salificado, amino, mono, dialquilamino, ariltio y los radicales ciclicos que comprenden 3 a 4eslabones, estando ademas los radicales alquilo, alquenilo o alquinilo, eventualmente interrumpidos por uno o varios atomos de oxigeno, de nitrogeno ode azufre, estando todos los atomos de azufre eventualmente oxidados en forma de sulfoxido o de sulfona, estando ademas los radicales arilo y aralquiloeventualmentesustit uidos con un radical alquilo, alquenilo o alquinilo; R4 y R5 son o bien identicos o diferentes, representan un atomo de hidrogeno o unradical alquilo, eventualmente sustituido con uno o varios sustituyentes escogidos entre los atomosde halo geno, el radical hidroxilo, eventualmenteesterificado, esterificado o protegido y los radicales feniltio y alquiltio, en los que el atomo de azufre puede estar oxidado en forma de sulfoxido o sulfonay estando eventualmente sustituido con unoo varios radicales escogidos entre atomos de halogeno, y los radicales hidroxilo eventualmente esterificado,
ARP960105163A 1995-11-16 1996-11-13 Procedimiento de preparacion de derivados de fenilimidazolidina AR004965A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9513589A FR2741346B1 (fr) 1995-11-16 1995-11-16 Nouveau procede de preparation de derives phenylimidazolidine

Publications (1)

Publication Number Publication Date
AR004965A1 true AR004965A1 (es) 1999-04-07

Family

ID=9484624

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105163A AR004965A1 (es) 1995-11-16 1996-11-13 Procedimiento de preparacion de derivados de fenilimidazolidina

Country Status (29)

Country Link
US (1) US6107488A (es)
EP (1) EP0877738B1 (es)
JP (1) JP2000500150A (es)
KR (1) KR100466991B1 (es)
CN (1) CN1131219C (es)
AR (1) AR004965A1 (es)
AT (1) ATE240300T1 (es)
AU (1) AU718832B2 (es)
BR (1) BR9611573A (es)
CA (1) CA2235335A1 (es)
CU (1) CU22890A3 (es)
CZ (1) CZ144498A3 (es)
DE (1) DE69628203T2 (es)
DK (1) DK0877738T3 (es)
EA (1) EA002658B1 (es)
ES (1) ES2193271T3 (es)
FR (1) FR2741346B1 (es)
HU (1) HUP9904034A3 (es)
IL (1) IL124382A0 (es)
MX (1) MX9803730A (es)
NO (1) NO316514B1 (es)
PL (1) PL189697B1 (es)
PT (1) PT877738E (es)
SI (1) SI0877738T1 (es)
TR (1) TR199800865T2 (es)
TW (1) TW404942B (es)
UA (1) UA67720C2 (es)
WO (1) WO1997018197A1 (es)
ZA (1) ZA969442B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007514442A (ja) * 2003-12-19 2007-06-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 前立腺癌治療を評価するための方法および物質
NZ550102A (en) * 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
CN101454002B (zh) * 2006-03-27 2011-06-08 加利福尼亚大学董事会 用于治疗前列腺癌和与雄激素受体相关的疾病的雄激素受体调节剂
KR20160027254A (ko) 2006-03-29 2016-03-09 더 리전트 오브 더 유니버시티 오브 캘리포니아 디아릴티오히단토인 화합물
JP5535925B2 (ja) 2007-10-26 2014-07-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アンドロゲン受容体調節物質としてのジアリールヒダントイン化合物
CN102481294A (zh) 2009-09-11 2012-05-30 拜耳医药股份有限公司 作为抗癌药物的取代(杂芳基甲基)乙内酰硫脲
JP5749269B2 (ja) 2009-09-15 2015-07-15 マイラン・グループ ネガ型輻射線感応性リソグラフィック印刷プレートのための輻射線感応性コーティング組成物用のコポリマー、前記コポリマーを含むポリマー粒子、及びコポリマーバインダー
CA2787083C (en) 2010-02-16 2018-05-22 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
WO2011006265A2 (en) 2010-09-14 2011-01-20 Mylan Group Copolymers for near-infrared radiation-sensitive coating compositions for positive-working thermal lithographic printing plates
IL312316A (en) 2012-09-26 2024-06-01 Aragon Pharmaceuticals Inc Antiandrogens for the treatment of castration-resistant prostate cancer without metastases
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CA3079135A1 (en) 2017-10-16 2019-04-25 Arturo Molina Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
CN108218784A (zh) * 2018-01-16 2018-06-29 吴江信凯医药科技有限公司 一种尼鲁米特的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4916937B1 (es) * 1970-01-21 1974-04-25
JPS5136332B1 (es) * 1970-12-09 1976-10-07
CH544491A (de) * 1971-03-16 1973-11-30 Ciba Geigy Ag Herbizides Mittel
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
JPS57197268A (en) * 1981-05-29 1982-12-03 Sumitomo Chem Co Ltd Substituted phenylhydantoin derivative, its preparation, and herbicide containing the same as active ingredient
JPS62298562A (ja) * 1986-06-17 1987-12-25 Nippon Kayaku Co Ltd ブロモアニリン類の製造法
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2694290B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
EP0877738B1 (fr) 2003-05-14
EA199800378A1 (ru) 1998-10-29
DE69628203D1 (de) 2003-06-18
US6107488A (en) 2000-08-22
CN1131219C (zh) 2003-12-17
EP0877738A1 (fr) 1998-11-18
ES2193271T3 (es) 2003-11-01
DE69628203T2 (de) 2004-02-05
NO316514B1 (no) 2004-02-02
CU22890A3 (es) 2004-01-23
TR199800865T2 (xx) 1998-08-21
KR100466991B1 (ko) 2005-04-06
WO1997018197A1 (fr) 1997-05-22
PL326491A1 (en) 1998-09-28
IL124382A0 (en) 1998-12-06
TW404942B (en) 2000-09-11
PL189697B1 (pl) 2005-09-30
AU718832B2 (en) 2000-04-20
ATE240300T1 (de) 2003-05-15
CN1207732A (zh) 1999-02-10
UA67720C2 (en) 2004-07-15
AU7577396A (en) 1997-06-05
BR9611573A (pt) 1999-05-11
PT877738E (pt) 2003-09-30
CZ144498A3 (cs) 1998-09-16
DK0877738T3 (da) 2003-09-08
HUP9904034A3 (en) 2001-08-28
FR2741346B1 (fr) 1997-12-19
KR19990067639A (ko) 1999-08-25
HUP9904034A2 (hu) 2000-05-28
MX9803730A (es) 1998-11-30
JP2000500150A (ja) 2000-01-11
FR2741346A1 (fr) 1997-05-23
NO982237L (no) 1998-07-10
SI0877738T1 (en) 2003-10-31
NO982237D0 (no) 1998-05-15
ZA969442B (en) 1997-11-11
EA002658B1 (ru) 2002-08-29
CA2235335A1 (fr) 1997-05-22

Similar Documents

Publication Publication Date Title
AR004965A1 (es) Procedimiento de preparacion de derivados de fenilimidazolidina
TR199903025T2 (xx) 4-Fenilpiperidin bile�imleri.
CO5021135A1 (es) Compuestos quimicos
CY1112130T1 (el) Ενεργοποιητης για υποδοχεα δελτα αποκρινομενος σε πολλαπλασιαστη υπεροξειδιοσωματος
CO4700576A1 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que los contienen
NL350077I1 (nl) Cyprosulfamide
TR200002157T2 (tr) Kimyasal bileşikler
AR016131A1 (es) -oxazolidinonas triciclicamente substituidas, procedimientos para su preparacion, uso de dichos compuestos y medicamentos.
CO5601018A2 (es) Derivados de n-fenil-2-pirimidin-amina
NO20013379L (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
AR004195A1 (es) Nuevos derivados de la 5-0 desosaminil-6-0-metil-eritronolida a, su procedimiento de preparacion, compuestos intermediarios, metodo de aplicacionde los mismos para la preparacion de productos biologicamente activos.
DE69705480D1 (de) Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES2142773B1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
ES471245A1 (es) Un procedimiento para la preparacion de una composicion her-bicida a base de derivados de n'-fenil-n-metilurea
ATE262509T1 (de) Indolinderivate als lichtschutzmittel
DK0807627T3 (da) Anilidforbindelser som ACAT-inhibitorer
BR9902084A (pt) Heterociclos.
AR015311A1 (es) Compuestos diaril selenuros, composiciones farmaceuticas y composiciones cosmeticas que comprenden al menos uno de dichos compuestos y utilizacion de la composicion cosmetica
ES2037011T3 (es) Procedimiento para la preparacion de nuevos derivados de benzofuran-2-il-imidazol.
ATE328055T1 (de) Substituierte lineare thioureaverbindungen als schmiermittelzusatzstoff
ATE425140T1 (de) Mercaptane und disulfide
AR023300A1 (es) COMPUESTOS HETEROETINILENADOS, COMPOSICIONES FARMACÉUTICAS Y COSMÉTICAS QUE LOS COMPRENDEN Y UTILIZACIoN COSMÉTICA DE LA COMPOSICIoN COSMÉTICA PARA LA HIGIENE CORPORAL O CAPILAR.
ES2194696T3 (es) Compuestos quimicos.
ES2035919T3 (es) Composiciones fungicidas.